Kasper Roet

Kasper Roet

Company: QurAlis

Job title: Founder & Chief Executive Officer


Harnessing New Insights into Human Genetics & Stem Cell Technology to Provide Genetically-Validated Targets for the Sporadic ALS Patient Populations 8:30 am

Investigating genetically validated targets in ALS patient-derived cells to develop precision therapeutics Examining the emerging role of aberrant splicing in the development of disease Highlighting the need of human model systems to select the right therapeutic candidate moleculesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.